Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: Effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog

Endocrine Research

Volumn 22, Issue 2, 1996, Pages 159-174

  Giustina, A ^a,d   Desenzani, P ^a   Perini, P ^a   Deghenghi, R ^b   Bugari, G ^a   Wehrenberg, W B ^c   Giustina, G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Ardana   (France)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SOMATOSTATIN;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOTHALAMUS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029886860     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1080/07435809609030505     Document Type: Article

References (36)

1. Lundbaek K, Christensen NJ, Jensen VA, Johansen K, Steen Olsen T, Prange Hansen A, et al. 1970 Diabetes, diabetic angiopathy, and growth hormone. Lancet 2: 131-133.
2. Østerby R, Seyer-Hasen K, Gundersen HJG, Lundbaek K. 1978 Growth hormone enhances basement membrane thickening in experimental diabetes. Diabetologia 15: 487-489.
3. Gerich JE. 1984 Role of growth hormone in diabetes mellitus. N Engl J Med 310: 848-850.
4. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K, et al. 1985 The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60: 523-6.
5. Hayford JT, Danney MM, Hendrix JA, thompson RG. 1980 Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 29: 391-398.
6. Hansen AP. 1970 Abnormal serum growth hormone responses to exercise in juvenile diabetics. J Clin Invest 49: 1467-1478.
7. Press M, Caprio S, Tamborlane WV, Bhushan R, Thorner MO, Vale W, et al. 1992 Pituitary response to growth hormone releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes 41: 17-21.
8. Cremer GM, Molnar GD, Taylor WF, Rosevear JW, Ackerman E. 1973 Growth hormone release in unstable diabetes. Tests with saline, arginine, glucagon and epinephrine. Acta Diabetol Lat 10: 1216-1221.
9. Valentini U, Cimino A, Rotondi A, Rocca L, Pelizzari R, Giustina A, et al. 1989 Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetics. J Endocrinol Invest 12: 643-6.
10. Giustina A, Bossoni S, Licini M, Macca C, Milani G, Wehrenberg WB. 1994 Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment. Endocr Res 20: 151-164.
11. Pietschmann P, Schernthaner G, Prskavec F, Gisinger C, Freyler H. 1987 No evidence for increased growth hormone responses to growth hormone-releasing hormone in patients with diabetic retinopathy. Diabetes 36: 159-162.
12. Krassowski J, Felber JP, Rogala H, Jeske W, Zgliczynski S. 1988 Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol (Copenh) 117: 225-229.
13. Press M, Tamborlane WV, Thorner MO, Vale W, Rivier J, Gertner JM, et al. 1984 Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression. Diabetes 33: 804-806.
14. Giustina A, Bossoni S, Cimino A, Pizzocolo G, Romanelli G, Wehrenberg WB. 1990 Impaired growth hormone (GH) response to pyridostigmine in type I diabetic patients with exaggerated GH releasing hormone stimulated GH secretion. J Clin Endocrinol Metab 71: 1486-1490.
15. Ismail IS, Scanlon MF, Peters JR. 1993 Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin-dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. Clin Endocrinol (Oxf) 38: 149-157.
16. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537-1545.
17. Goth MI, Lyons CE, Canny BJ, Thorner MO. 1992 Pituitary adenilate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptor. Endocrinology 130: 939-944.
18. Conley LK, Teik SA, Deghenghi R, Imbimbo BP, Giustina A, Locatelli V, et al. 1995 Mechanism of action of hexarelin and GHRP-6: Analysis of the involvement of GHRH and somatostatin. Neuroendocrinology 61: 44-50.
19. 2), a new GH-releasing peptide, is biologically active in male and female rats. Endocrine Journal 2: 691-695.
20. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Leanerts V, Deghenghi R, et al. 1994 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab 78: 693-698.
21. Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, et al. 1995 Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metab 44(1): 134-138.
22. Diabetic Retinopathy Study Research Group. 1981 Report 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophtalmol Vis Sci 21: 210-226.
23. Giustina A, Bossoni S, Cimino A, Comini MT, Gazzoli N, Leproux GB, et al. 1993 Picotamide a dual TXB synthetase inhibitor and TXB receptor antagonist, reduce exercise-induced albuminuria in microalbuminuric patients with NIDDM. Diabetes 42: 178-182.
24. Asplin CM, Faria ACS, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, et al. 1989 Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69: 239-245.
25. Wehrenberg WB, Wiviott SD, Voltz DM, Giustina A. 1992 Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 130: 1445-1450.
26. Ross RJM, Borges F, Grossman A, Smith R, Ngahfoong L, Rees LH, et al. 1987 Growth hormone pretreatment in man blocks the response to growth hormone releasing hormone: evidence for a direct effect of growth hormone. Clin Endocrinol (Oxf) 26: 117-123.
27. Giustina A, Bossoni S, Bodini C, Cimino A, Pizzocolo G, Schettino M, et al. 1991 Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Acta Endocrinol (Copenh) 125: 510-517.
28. Schaper NC. 1990 Growth hormone secretion in type I diabetes. A review. Acta Endocrinol (Copenh) 122 (Suppl.2): 7-12.
29. Codd EE, Shu AY, Walker RF. 1989 Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28: 1139-1144.
30. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner M. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts sinergistically with GH-releasing hormone. J Clin Endocrinol Metab 70: 975-982.
31. Voltz DM, Piering AW, Magestro M, Giustina A, Wehrenberg WB. 1995 Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment. Life Sci 56: 491-497.
32. Giustina A, Bossoni S, Bodini C, Doga M, Girelli A, Buffoli MG, et al. 1991 The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man. Metab 40: 519-523.
33. Giustina A, Wehrenberg WB. 1994 Growth hormone neuroregulation in diabetes mellitus. Trends Endocrinol Metab 5: 73-78.
34. Cahill GF Jr, McDevitt HO. 1981 Insulin dependent diabetes mellitus: the initial lesion. N Engl J Med 304: 1454-1465.
35. Martino GV, Tappaz M, Braghi S, Dozio N, Canal N, Pozza G, et al. 1991 Autoantibodies to glutamic acid decarboxilase (GAD) detected by an immuno-trapping enzyme activity assay: relation to in insulin-dependent diabetes mellitus and islet cell antibodies. J Autoimmun 4: 915-923.
36. Giustina A, Bresciani E, Tassi C, Girelli A, Valentini U. 1994 Effect of pyridostigmine on the growth hormone response to growth hormone releasing hormone in lean and obese type 2 diabetic patients. Metabolism 43: 893-898.